A couple of days ago we reported that USACIG has secured a deal with Hop-on to act as their agent to submit an application to the FDA to allow them to begin clinical studies to see if their Electric Cigarette could be an effective treatment for Parkinson's Disease.

This was a surprise move to many people, me included. So i've been looking into it.

Yes, there is some evidence that nicotine could be a treatment for PD and it's been shown smoking may be a major factor in the reason smokers have a lower instance of PD than non smokers. One study from the College of Medicine at the University of Vermont concluded:

We have begun quantitative studies of both acute and chronic nicotine in PD to assess both cognitive and motor effects. Fifteen (15) nondemented subjects (age 66 +/- 5.3; M/F = 11/4) with early to moderate PD (mean Hoehn-Yahr stage = 1.77; MMSE = 28.6) received a dose-ranging study of intravenous nicotine up to 1.25 microg/kg/min, followed by chronic administration of nicotine by transdermal patch with doses ranging up to 14 mg per day for 2 weeks. Testing occurred both during drug administration and up to 2 months after drug cessation to look for prolonged effects.

Read more

USACIG, maker of the "Electric Cigarette" announced they have signed an exclusive agreement with Hop-on to submit it's electronic cigarette technology to the FDA for clinical studies for the prevention and treatment of Parkinson's disease.

Recent studies by the Parkinson's Institute and Clinical Center lead by Maryka Quik, Ph D have indicated intermittent nicotine treatment can reduce medication induced dyskinesias by as much as 50%. USACIG is hoping their electronic cigarette might be the perfect way to deliver nicotine to Parkinson's patients.

Peter Michaels, CEO of Hop-on, the company one usually associates with multi media services, the first disposable cell phone and the licencing of technology like CDMA, GSM and WIFI, says they are excited to be the exclusive agent for FDA submission.